Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study.
Adaia Albasanz-PuigCarlota GudiolRocío ParodyCristian TebeMurat AkovaRafael AraosAnna BoteAnne-Sophie BrunelSebnem CalikLubos DrgonaEstefanía GarcíaPhilipp HemmatiFabián HerreraKarim Yaqub IbrahimBurcu IslerSouha KanjWinfried KernGuillermo Maestro de la CalleAdriana ManzurJorge Iván MarinIgnacio Márquez-GómezPilar Martín-DávilaMalgorzata MikulskaJosé Miguel MontejoMilagros MonteroHugo Manuel Paz MoralesIsabel MoralesAndrés NovoChiara OltoliniMaddalena PeghinJose Luis Del PozoPedro Puerta-AlcaldeIsabel Ruiz-CampsOguz Resat SipahiRobert TilleyLucrecia YáñezMarisa Zenaide Ribeiro GomesJordi Carratalànull nullPublished in: BMJ open (2019)
The Clinical Research Ethics Committee of Bellvitge University Hospital approved the protocol of the study at the primary site. To protect personal privacy, identifying information of each patient in the electronic database will be encrypted. The processing of the patients' personal data collected in the study will comply with the Spanish Data Protection Act of 1998 and with the European Directive on the privacy of data. All data collected, stored and processed will be anonymised. Results will be reported at conferences and in peer-reviewed publications.
Keyphrases
- big data
- pseudomonas aeruginosa
- study protocol
- randomized controlled trial
- electronic health record
- squamous cell carcinoma
- end stage renal disease
- healthcare
- chronic kidney disease
- machine learning
- metabolic syndrome
- ejection fraction
- newly diagnosed
- artificial intelligence
- adipose tissue
- health information
- skeletal muscle
- cross sectional
- insulin resistance
- case report
- open label
- global health